Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8865 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8792 |
High Similarity |
NPD7819 |
Suspended |
0.8759 |
High Similarity |
NPD2533 |
Approved |
0.8759 |
High Similarity |
NPD2534 |
Approved |
0.8759 |
High Similarity |
NPD2532 |
Approved |
0.8452 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8377 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8301 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8276 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8264 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8219 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8165 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8165 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8165 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8112 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8082 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8056 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8041 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7962 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7959 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7947 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7914 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7911 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7838 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7838 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7838 |
Intermediate Similarity |
NPD5408 |
Approved |
0.781 |
Intermediate Similarity |
NPD9545 |
Approved |
0.78 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7799 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD920 |
Approved |
0.7785 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD943 |
Approved |
0.7736 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.773 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7702 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7664 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7651 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7651 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7647 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD1512 |
Approved |
0.761 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD3764 |
Approved |
0.76 |
Intermediate Similarity |
NPD6100 |
Approved |
0.76 |
Intermediate Similarity |
NPD6099 |
Approved |
0.759 |
Intermediate Similarity |
NPD7054 |
Approved |
0.759 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7589 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7544 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD919 |
Approved |
0.753 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1470 |
Approved |
0.75 |
Intermediate Similarity |
NPD1164 |
Approved |
0.75 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7452 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD37 |
Approved |
0.7325 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7325 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7301 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7301 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7286 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7267 |
Intermediate Similarity |
NPD8313 |
Approved |
0.726 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7254 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7222 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6534 |
Approved |
0.719 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1608 |
Approved |
0.716 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7133 |
Intermediate Similarity |
NPD411 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD1247 |
Approved |
0.712 |
Intermediate Similarity |
NPD8319 |
Approved |
0.712 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7118 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7105 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7095 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7088 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7088 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6663 |
Approved |
0.708 |
Intermediate Similarity |
NPD74 |
Approved |
0.708 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7072 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7047 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7044 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7032 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7032 |
Intermediate Similarity |
NPD4476 |
Approved |
0.703 |
Intermediate Similarity |
NPD4288 |
Approved |
0.703 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2309 |
Approved |
0.702 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7017 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD9264 |
Approved |
0.6989 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6986
|
Remote Similarity |
NPD1281 |
Approved |